Research & Innovation Published on April 24, 2026

Peptide analytics: high-resolution LC-MS, NMR, HPLC and Edman - Complete research guide

13 min read
Cover image: Peptide analytics: high-resolution LC-MS, NMR, HPLC and Edman - Complete research guide

A COA without detailed analytical methods is worthless paper. Complete characterization of a research peptide today mobilizes ten complementary techniques, each sensitive to a distinct aspect of structure or purity. This comprehensive guide dissects the physical principles, detection limits, QC strategies and common pitfalls of each method. It completes the SPPS synthesis and peptide stability pillars to form the methodological trilogy of serious laboratories.

RP-HPLC: the purity gold standard

Reverse-phase high-performance liquid chromatography (RP-HPLC) separates peptides by hydrophobicity. The stationary phase is typically C18 silica (octadecyl, 18-carbon alkyl chains), sometimes C8 or C4 for very hydrophobic peptides. The mobile phase is a water/acetonitrile gradient acidified with 0.1% trifluoroacetic acid (TFA).

Analytical vs preparative columns

An analytical column typically measures 150 x 4.6 mm with 3 to 5 micron particles, flow 1 mL/min, injection 10-50 microg. A preparative column measures 250 x 21 mm to 250 x 50 mm, flow 10 to 100 mL/min, load 10 to 500 mg per injection. UPLC columns (1.7 micron particles) reduce analysis time to 10 min with superior resolution.

Detection: UV, ELSD and fluorescence

UV detection at 214 nm targets the peptide bond (near-universal absorption of all peptides). Detection at 280 nm is specific to aromatic Trp and Tyr residues (higher extinction coefficient). For chromophore-less peptides, ELSD (evaporative light scattering detector) or CAD (charged aerosol detector) give mass-proportional response.

Purity expression

HPLC purity is expressed as percentage of integrated area of main peak relative to total peak area above a defined threshold (typically 0.1 or 0.05%). A research-grade peptide typically displays 95 to 98% HPLC. Pharmaceutical APIs (active pharmaceutical ingredients) generally require > 99%.

Limits and pitfalls

RP-HPLC does not distinguish two isomers of same hydrophobicity (e.g., Asp vs isoAsp). It can mask impurities co-eluting with main peak. It does not chemically identify detected impurities (hence LC-MS necessity). A broad peak or shoulder typically signals aggregation or isomerization.

High-resolution LC-MS: molecular identification

Liquid chromatography coupled to mass spectrometry (LC-MS) is today's reference identification tool. Two instrument families dominate peptide characterization:

Orbitrap: ultimate resolution

The Orbitrap (invented by Alexander Makarov, commercialized by Thermo Scientific since 2005) traps ions around a central electrode and measures oscillation frequency by Fourier transform. Resolution > 100 000 FWHM at m/z 400, mass accuracy < 2 ppm. Distinguishes isobars like N-15 isotope vs CH4 (0.006 Da differences).

QTOF: speed

The quadrupole time-of-flight (QTOF) combines quadrupole selection and TOF analyzer. Resolution 40 000 to 60 000 FWHM, accuracy 5-10 ppm, rapid acquisition suited to LC-UPLC coupling.

Ionization: ESI for peptides

Electrospray (ESI) is the universal peptide ionization source. Peptides multiply charge in acidic solution, generating [M+2H]2+, [M+3H]3+ ions, etc. For a 4731 Da retatrutide, one typically observes ions at m/z 1578 ([M+3H]3+), 1184 ([M+4H]4+), 947 ([M+5H]5+). Exact monoisotopic mass is calculated by deconvolution.

MS/MS fragmentation: CID, HCD, ETD

Peptide ion fragmentation generates b fragments (N-terminal side) and y fragments (C-terminal side) per Roepstorff-Fohlman nomenclature. Three modes:

  • CID (collision-induced dissociation): collision with inert gas (N2, Ar), medium energy, peptide bond fragmentation, majority b/y ions. Standard in sequence identification.
  • HCD (higher-energy collisional dissociation): higher energy, visible immonium fragments (useful for AAA), preferred on Orbitrap.
  • ETD (electron transfer dissociation): radical electron transfer, generates c/z fragments without losing fragile post-translational modifications (phosphorylation, glycosylation). Essential for characterizing modified peptides.

Peptide mapping

Enzymatic digestion (trypsin, Lys-C, Asp-N, chymotrypsin) of peptide or its protein generates a fragment set analyzed by LC-MS/MS. Expected sequence coverage exceeds 95% for medium-size peptides. Mapping detects: (1) confirmed sequence, (2) degradation sites (Met oxidation, Asn deamidation), (3) modifications (N-terminal pyroglutamate, disulfides). Tryptic digestion cleaves after Arg and Lys (unless followed by Pro), generating 6-20 residue fragments ideal for MS/MS.

NMR: atomic structure in solution

Nuclear magnetic resonance (NMR) gives the only complete atomic view of peptide in solution. It mobilizes 1H, 13C, 15N and sometimes 31P nuclei. For unlabeled peptide, 1H NMR suffices; for peptides > 30 residues, 15N and 13C labeling improves spectral dispersion.

Classic 2D experiments

  • COSY (correlation spectroscopy): scalar J correlations between protons of same residue (H-alpha / H-beta / H-gamma). Identifies spin systems.
  • TOCSY (total correlation spectroscopy): long-range scalar correlations in complete spin system. Assigns all protons of a residue.
  • NOESY (nuclear Overhauser effect spectroscopy): dipolar correlations between spatially close protons (< 5 A). Reveals three-dimensional structure.
  • ROESY: NOESY variant suited to medium-size molecules (1-3 kDa).
  • HSQC (heteronuclear single quantum coherence): direct 1H-13C or 1H-15N correlations. Requires isotopic labeling.

Applications

NMR confirms: (1) primary sequence unambiguously, (2) secondary structure (alpha helix vs beta sheet vs random coil), (3) 3D conformation (for cyclic peptides like MT-II), (4) conformational dynamics (slow/fast exchange), (5) subtle chemical modifications (Met oxidation, Asp isomerization). Resolution typically requires 1-10 mg peptide for complete experiment.

Edman degradation: N-terminal sequencing

Edman degradation (Pehr Edman, Nature 1950) is the historical peptide sequencing method. Cyclic principle: coupling phenyl-isothiocyanate (PITC) to N-terminal amine, acid cleavage of first residue as phenylthiohydantoin (PTH-AA), HPLC identification of each PTH, cycle repetition.

Performance and limits

A modern sequencer (Shimadzu PPSQ, Procise 494) identifies 20 to 50 residues per analysis. Detects only free N-termini (Edman fails on blocked N-terminus pyroglutamate, acetyl). Required quantity: 50-500 pmol. Reliably detects modifications like phosphorylation, hydroxylation, methylation by comparing to corresponding PTH-AA standard. Edman degradation remains the gold standard for confirming a free N-terminus and detecting sequence impurities (insertion, deletion of a residue).

Circular dichroism (CD): secondary structure

Circular dichroism (CD) measures left vs right circular light absorption difference by a chiral chromophore (peptide bond). Far UV spectra (190-250 nm) diagnose secondary structure:

  • Alpha helix: two minima at 208 and 222 nm, maximum at 192 nm.
  • Beta sheet: minimum at 218 nm, maximum at 195 nm.
  • Random coil: minimum at 200 nm, absence of 222 nm signal.

Deconvolution (K2D3, CDSSTR, Selcon algorithms) gives quantitative composition in percent helix, sheet, turn and random coil. Applications: (1) expected structure verification, (2) unfolding detection after thermal stress (Tm by CD at 222 nm), (3) aggregation monitoring.

FTIR and Raman: vibrational complementarity

Fourier-transform infrared (FTIR) analyzes molecular vibrations. The amide I band (1600-1700 cm-1, C=O vibration) informs on secondary structure: 1650 cm-1 = alpha helix, 1625-1640 cm-1 = beta sheet, 1670-1685 cm-1 = turn. Amide II (1500-1600 cm-1, N-H bending + C-N stretching) confirms. Raman spectroscopy, complementary, detects modes inaccessible in IR.

AAA: amino acid analysis

Amino acid analysis (AAA) gives exact composition: acid hydrolysis (6 N HCl, 110°C, 24h) of peptide into free amino acids, derivatization (ninhydrin, OPA, AQC) and HPLC separation. Theoretical yield: 100% for stable amino acids, controlled losses for Trp (partial destruction), Cys (oxidation to cysteic acid), Ser/Thr (partial destruction). AAA gives absolute quantification (peptide titer) and confirms expected composition at +/- 5% per residue.

Critical accessory techniques

Karl Fischer: water content

Coulometric Karl Fischer titration measures residual water content of lyophilized peptide with 10 microg water detection limit. Post-lyophilization target: < 1%, ideal < 0.5%. Content > 2% signals failed lyophilization and predicts accelerated degradation.

ICP-MS: metal traces

ICP-MS (inductively coupled plasma mass spectrometry) quantifies metal traces (Fe, Cu, Zn, Pb, Cd, As) at ppb. Essential because transition metals catalyze Met/Cys oxidation. Pharmacopoeia limit: generally < 1 ppm total. Synthesis catalyst residues (Pd from Suzuki coupling, Cu from click chemistry) must be controlled.

DLS: submicron oligomers

Dynamic light scattering (DLS) measures hydrodynamic diameter of 1 nm to 1 micron particles. Early-detects 20-100 nm aggregates well before visible turbidity. Sensitivity: a few mg/mL suffice. Indispensable for amyloidogenic peptides.

DSC: thermal transition

Differential scanning calorimetry (DSC) measures Tm (peptide structure melting temperature) and Tg' (frozen phase glass transition temperature). Applications: (1) verify lyophilized cake integrity (expected Tg'), (2) compare conformational stability of variants (Tm in solution).

Absolute quantification: AQUA and SILAC

Absolute peptide quantification by MS uses two approaches:

  • AQUA (absolute quantification): addition of identical-sequence 13C/15N-labeled peptide internal standard, MRM (multiple reaction monitoring) detection in triple quadrupole LC-MS/MS.
  • SILAC (stable isotope labeling by amino acids in cell culture): in vivo metabolic labeling by incorporation of labeled amino acids. Reserved for systems biology applications.

Expected precision: +/- 10% under standard conditions, +/- 2% under advanced MRM optimization.

Integrated QC strategy

A complete research-grade peptide typically mobilizes 5 minimum methods on COA:

  1. RP-HPLC (global purity, chromatogram at 214 nm)
  2. High-resolution LC-MS (exact mass, molecular confirmation)
  3. MS/MS (complete sequence confirmation via fragmentation)
  4. AAA (peptide titer, confirmed composition)
  5. Karl Fischer water content (< 1%)

Advanced analyses (NMR, CD, FTIR, DLS, DSC, ICP-MS, Edman) are reserved for critical batches, initial new product characterization, or deviation investigations. A reference laboratory maintains a spectra library for systematic comparison.

Common pitfalls and errors

  • HPLC purity at different threshold: same peptide announced at 98% with 0.5% threshold may be 95% at 0.1%. Always verify declared threshold.
  • Correct MS mass but co-eluting impurities: a peptide can show correct mass but contain 10% MS-invisible isomers.
  • Edman that fails: blocked N-terminus pyroglutamate, acetyl, formyl. Deblock with pyroglutamate aminopeptidase before Edman.
  • Ambiguous CD: short peptides (< 15 residues) often give random coil spectra even with local structure.
  • AAA with destroyed Trp: classic hydrolysis destroys 50-100% of Trp. Alternative methanesulfonic acid hydrolysis preserves Trp.

FAQ - Peptide analytics

How much does complete peptide characterization analysis cost?

For a standard research-grade peptide, the RP-HPLC + LC-MS + MS/MS pack typically costs 200-500 euros per batch in external services. Adding AAA and Karl Fischer rises to 500-800 euros. Complete characterization with 2D NMR, CD, FTIR and DSC exceeds 2000-3000 euros. University laboratories often offer academic rates 30-50% lower.

How to interpret an HPLC chromatogram with multiple peaks?

A chromatogram with 2-5 minor peaks (< 2% each) around the main peak typically reflects synthesis impurities: truncated peptides (residue deletion), peptides with deletion, incomplete deprotection products, or degradations (Met oxidation gives +16 Da peak eluting earlier). A single peak at 95-98% is a correct peptide. A 90% peak with 5% major impurity must be characterized by LC-MS to identify impurity nature.

Why are LC-MS and RP-HPLC alone insufficient to certify a peptide?

RP-HPLC measures chromatographic purity but does not confirm sequence. LC-MS gives mass but does not distinguish two peptides with same amino acid composition but different sequence (isomers). MS/MS combination (fragmentation) is indispensable to confirm sequence. AAA validates absolute composition. A minimum research-grade certified peptide mobilizes the 4 methods.

How to detect Asn -> Asp deamidation early?

Deamidation adds +1 Da and introduces additional negative charge. Three methods: (1) high-resolution LC-MS detects +1 Da shift with < 2 ppm precision on Orbitrap, (2) RP-HPLC with suitable column separates Asn and Asp by typically +0.5 min peak, (3) peptide mapping with Asp-N digestion generating different fragments after deamidation. Early detection avoids publishing results on partially degraded peptide.

Emerging and cutting-edge techniques

Peptide analytics evolves rapidly under pressure from increasing regulatory requirements and the rise of complex therapeutic peptides (conjugates, lipopeptides, macrocyclic cyclic peptides).

Ion mobility (IM-MS)

Ion mobility spectrometry coupled to MS (IM-MS) separates ions by their collisional cross section (CCS) measured in A2. It discriminates conformational isomers and folded vs unfolded forms that MS alone confuses. Commercial instruments (Waters Synapt, Bruker timsTOF, Agilent 6560) add a separation dimension without extending analysis duration. Useful for characterizing macrocyclic cyclic peptides and complex disulfide peptides.

HDX-MS (hydrogen-deuterium exchange)

Hydrogen-deuterium exchange coupled to MS measures conformational dynamics and solvent accessibility of each peptide region. Principle: D2O incubation, rapid pH 2.5 digestion to minimize back-exchange, MS analysis with deuterium incorporation quantification per fragment. Application: map peptide-receptor interactions and conformational impact of chemical modifications.

Native MS

Native mass spectrometry (in quasi-physiological conditions, ammonium acetate buffer pH 6-8) preserves non-covalent interactions: dimers, peptide micelles, peptide-protein complexes. Useful for studying GLP-1 micellar analog self-association or ligand-albumin complexes.

Cryo-electron microscopy (cryo-EM)

For peptides associated with membrane proteins (peptide-receptor complexes), single-particle cryo-EM today resolves structures at 2.5-3.5 A. Several GLP-1R-semaglutide and GLP-1R-tirzepatide complex structures are published in Nature and Cell since 2020.

Typical workflows by project type

Reception of a new production batch

Standard reception QC: (1) visual inspection of lyophilized cake, (2) analytical RP-HPLC to confirm purity and impurity profile vs reference batch, (3) high-resolution LC-MS to confirm mass, (4) Karl Fischer for water content. Total duration: 24-48h in equipped laboratory. A batch is releasable if purity > 95%, correct mass +/- 0.01%, water < 1%.

Investigation of a purity deviation

If a batch shows 92% instead of expected 95+: (1) LC-MS of impurities to identify them (Met oxidation +16 Da, deamidation +1 Da, truncated peptide), (2) post-digestion peptide mapping to localize sites, (3) accelerated stability profile verification. Root cause determines whether the batch is salvageable by additional purification or must be destroyed.

Characterization of a new peptide

For a first R&D batch: RP-HPLC, LC-MS, complete MS/MS, AAA, 1D and 2D NMR if sufficient quantity (> 5 mg), CD for secondary structure, Karl Fischer. Complete pack 1500-3000 euros. This initial characterization dossier becomes the reference standard for all subsequent batches.

ICH accelerated stability

Stability monitoring over 6 months: samplings at 0, 1, 2, 3, 6 months. At each point: RP-HPLC + LC-MS + DLS. Impurity plot over time, expiration date extrapolation at t = 5% total impurity (pragmatic rule). Budget: 3000-5000 euros for a complete 24-month study.

Reference libraries and databases

Peptide analytics laboratories rely on several public databases:

  • UniProt: reference protein sequences, post-translational modifications.
  • PeptideAtlas: MS/MS reference spectra for millions of tryptic peptides.
  • BMRB (Biological Magnetic Resonance Data Bank): reference NMR chemical shifts.
  • PDB (Protein Data Bank): 3D structures resolved by NMR or cryo-EM.
  • MassBank, METLIN: MS spectra for unknown identification.

Related products

Retatrutide

Retatrutide

5mg
38,00 €
Retatrutide

Retatrutide

10mg
60,00 €
Tirzepatide

Tirzepatide

10mg
44,00 €
Semaglutide

Semaglutide

5mg
29,00 €
Cagrilintide

Cagrilintide

5mg
35,00 €
Melanotan 2

Melanotan 2

10mg
26,00 €
PT-141

PT-141

10mg
32,00 €
BPC-157

BPC-157

10mg
33,00 €
BPC-157

BPC-157

5mg
20,00 €
BPC-157 + TB-500

BPC-157 + TB-500

10mg + 10mg
59,00 €
CJC-1295 DAC

CJC-1295 DAC

5mg
32,00 €
GHRP-6

GHRP-6

10mg
24,00 €
Ipamorelin

Ipamorelin

5mg
27,00 €
Selank

Selank

5mg
27,00 €
Semax

Semax

5mg
27,00 €

Glossary terms

GLP-1 (Glucagon-Like Peptide-1)GLP-1 (Glucagon-Like Peptide-1) : hormone incrétine régulant la glycémie et l'appétit. Biologie, récepteur GLP-1R et analogues thérapeutiques (semaglutide, liraglutide).SémaglutideSémaglutide : agoniste GLP-1 long-acting (half-life 165h), peptide de recherche utilisé en études métaboliques et pondérales précliniques.TirzépatideTirzépatide : double agoniste GIP/GLP-1 (39aa, Aib2/Aib13, acylation C20), peptide de recherche métabolique d'étude (Mounjaro®).RétatrutideRétatrutide (LY3437943) : triple agoniste GLP-1/GIP/Glucagon, peptide de recherche de nouvelle génération, études TRIUMPH en cours.CagrilintideCagrilintide : analogue d'amyline à action longue (Novo Nordisk), peptide de recherche métabolique complémentaire des agonistes GLP-1.Melanotan IIMelanotan II : heptapeptide cyclique analogue de α-MSH, agoniste MC1R/MC3R/MC4R/MC5R, peptide de recherche (pigmentation, libido).DipeptideDipeptide : 2 acides aminés liés, carnosine, aspartame, rôle clé en recherche pharmaco et conception analogues RUO.PolypeptidePolypeptide : chaîne longue (20-100 aa), insuline, semaglutide, retatrutide, top recherche peptidique RUO.IncrétineIncrétine : hormone peptidique intestinale (GLP-1, GIP) stimulant la sécrétion d'insuline glucose-dépendante. Base des thérapies antidiabétiques.RP-HPLCRP-HPLC (chromatographie liquide haute performance en phase inverse) : méthode de référence pour la pureté et l'analyse de peptides.RMN (Résonance Magnétique Nucléaire)RMN : technique de caractérisation structurale 3D des peptides en solution, complément essentiel à la MS et aux RX.TFA (Acide Trifluoroacétique)TFA : acide organique fluoré, clef de voûte de la SPPS et de la RP-HPLC peptidique. Applications de clivage et ion-pairing.Numéro CASNuméro CAS : identifiant unique universel d'une molécule, clé pour traçabilité et conformité peptide RUO.API (Principe Actif Pharmaceutique)API (Active Pharmaceutical Ingredient) : substance active d'un médicament, soumise à BPF/GMP et référencée dans DMF/ASMF/CTD.USP (United States Pharmacopeia)USP : pharmacopée américaine de référence pour normes de qualité des médicaments. Chapitres clefs pour peptides et APIs.DPP-4 (Dipeptidyl-Peptidase 4)DPP-4 : sérine protéase clivant les dipeptides N-terminaux Xaa-Pro/Xaa-Ala. Inactive GLP-1, GIP, GHRH. Cible thérapeutique (gliptines).OligopeptideOligopeptide : 2 à 20 aa, enképhalines, BPC-157, cœur de gamme recherche peptidique RUO.AgonisteAgoniste : molécule qui se lie à un récepteur et active sa signalisation biologique, imitant l'effet du ligand endogène naturel.Peptide cycliquePeptide cyclique : types de cyclisation, avantages pharmacocinétiques, exemples naturels et synthétiques, applications en recherche.RécepteurRécepteur : protéine spécialisée, généralement membranaire, qui lie spécifiquement un ligand (hormone, peptide, neurotransmetteur) et déclenche une cascade de signalisation intracellulaire.

Similar articles

Cagrilintide (AM-833) : guide complet de l'analogue amyline longue durée en recherche métabolique
Research & Innovation

Cagrilintide (AM-833) : guide complet de l'analogue amyline longue durée en recherche métabolique

April 23, 2026
Comment lire un certificat d'analyse (COA) de peptide : guide complet du chercheur exigeant
Research & Innovation

Comment lire un certificat d'analyse (COA) de peptide : guide complet du chercheur exigeant

April 23, 2026
Mélanocortines en recherche : guide complet Melanotan II, PT-141 bremelanotide, afamelanotide et récepteurs MC1R-MC5R
Research & Innovation

Mélanocortines en recherche : guide complet Melanotan II, PT-141 bremelanotide, afamelanotide et récepteurs MC1R-MC5R

April 23, 2026
Retatrutide (LY3437943) : guide complet du triple agoniste
Research & Innovation

Retatrutide (LY3437943) : guide complet du triple agoniste

April 23, 2026
Sémaglutide en recherche : guide complet du mécanisme GLP-1R, pharmacocinétique et protocoles expérimentaux
Uses & Performance

Sémaglutide en recherche : guide complet du mécanisme GLP-1R, pharmacocinétique et protocoles expérimentaux

April 23, 2026
Stabilite peptidique : degradation, lyophilisation et stockage - Guide de reference pour la recherche
Research & Innovation

Stabilite peptidique : degradation, lyophilisation et stockage - Guide de reference pour la recherche

April 23, 2026
Synthèse peptidique en phase solide (SPPS) : guide complet Merrifield, Fmoc, Boc, résines, agents de couplage et contrôle qualité
Research & Innovation

Synthèse peptidique en phase solide (SPPS) : guide complet Merrifield, Fmoc, Boc, résines, agents de couplage et contrôle qualité

April 23, 2026
Tirzepatide : guide complet du co-agoniste GLP-1R / GIPR en recherche préclinique
Uses & Performance

Tirzepatide : guide complet du co-agoniste GLP-1R / GIPR en recherche préclinique

April 23, 2026
Verified sources
Scientific content
Written by experts